| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Regeneron Pharmaceuticals continues to lead in innovative treatment approaches, particularly highlighted by the approval of Dupixent, which offers new solutions for chronic inflammatory conditions. This innovation not only demonstrates the company's commitment to advancing healthcare but also enhances its competitive position in the pharmaceutical market. With a strong focus on research and development, Regeneron is setting new standards in treatment efficacy and patient outcomes. However, the market's response to ongoing regulatory approvals and potential competition remains a critical factor in its future success. |
| The price action of Regeneron Pharmaceuticals (REGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 0.7 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.REGN is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 0.8, and the negative at -0.1 on 2025-11-28. The forces of Sentiment towards Fundamentals (2), Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Valuation Sentiment (-0.7) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| REGN | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-28 | 0%(0%) | 1 | 0.25% | 0.6 | 2 | -1 | |||||||
| 2025-11-27 | 0%(0%) | 1 | 0.25% | 0.7 | 2.2 | -1 | |||||||
| 2025-11-26 | 0%(0%) | 1 | 0.25% | 0.8 | 2.9 | -1 | |||||||
| 2025-11-25 | 0%(0%) | 1 | 0.25% | 1.1 | 3.9 | -1 | |||||||
| 2025-11-24 | 0%(0%) | 1 | 0.25% | 1 | 3.4 | -1 | |||||||
| 2025-11-23 | 0%(0%) | 1 | 0.25% | 1 | 3.1 | -1 | |||||||
| 2025-11-22 | 0%(0%) | 1 | 0.25% | 0.9 | 3.6 | -1 | |||||||
| 2025-11-21 | 0%(0%) | 1 | 0.25% | 0.9 | 3.6 | -1 | |||||||
| 2025-11-20 | 0%(0%) | 1 | 0.25% | 0.7 | 2.6 | -1 | |||||||
| 2025-11-19 | 0%(0%) | 1 | 0.25% | 0.6 | 2.3 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-28 17:10:24 Changes in regulations can create uncertainties for biotech companies and may affect stock performance indirectly. |
| 2025-11-28 17:10:24 The closing stock price may imply broader market valuations regarding the company's future potential and financial health. |
| 2025-11-28 17:10:24 The context of stock movements can often involve competitive dynamics within the biopharmaceutical sector, though specifics are not outlined. |
| 2025-11-28 17:10:24 While detailed financial results are not provided, stock price movements often reflect expectations surrounding company earnings. |
| 2025-11-28 17:10:24 The article highlights the slight decline in the stock price of Regeneron Pharmaceuticals, indicating a short-term negative sentiment towards its stock performance. |